%D8%AF%D8%A7%D9%88%D9%86%D9%88%D8%B1%D9%88%D8%A8%D9%8A%D8%B3%D9%8A%D9%86%D8%AF%D8%A7%D9%86%D9%88%D8%B1%D9%88%D8%A8%DB%8C%D8%B3%DB%8C%D9%86DaunorubicinaCategory:DaunorubicinDawnorwbicinDaunorubicinDaunorubicinDaunorrubicina%D8%AF%D8%A7%D9%86%D9%88%D8%B1%D9%88%D8%A8%DB%8C%D8%B3%DB%8C%D9%86DaunorubisiiniDaunorubicineDaunorrubicina%D4%B4%D5%A1%D5%B8%D6%82%D5%B6%D5%B8%D5%BC%D5%B8%D6%82%D5%A2%D5%AB%D6%81%D5%AB%D5%B6Daunorubicina%E3%83%80%E3%82%A6%E3%83%8E%E3%83%AB%E3%83%93%E3%82%B7%E3%83%B3%E1%83%93%E1%83%90%E1%83%A3%E1%83%9C%E1%83%9D%E1%83%A0%E1%83%A3%E1%83%91%E1%83%98%E1%83%AA%E1%83%98%E1%83%9C%E1%83%98%EB%8B%A4%EC%9A%B0%EB%85%B8%EB%A3%A8%EB%B9%84%EC%8B%A0%E0%AC%A1%E0%AC%A8%E0%AD%8B%E0%AC%B0%E0%AD%81%E0%AC%AC%E0%AC%BF%E0%AC%B8%E0%AC%BF%E0%AC%A8DaunorubicynaDaunomicinaDaunorubicin%C4%83%D0%94%D0%B0%D1%83%D0%BD%D0%BE%D1%80%D1%83%D0%B1%D0%B8%D1%86%D0%B8%D0%BDDaunorubicinDavnorubicinDaunorubicinDaunorubisin%D0%94%D0%B0%D1%83%D0%BD%D0%BE%D1%80%D1%83%D0%B1%D1%96%D1%86%D0%B8%D0%BDDaunorubicinQ411659%E9%81%93%E8%AB%BE%E9%BB%B4%E7%B4%A0
about
P3355
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaPETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCombination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesTimed-Sequential Induction in CBF-AMLLiposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's SarcomaAML Treatment in Untreated Adult PatientsCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesA Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic SyndromeNHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic LymphomaPilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger PatientsAugmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic LymphomaPegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017Brentuximab Vedotin and Nivolumab in Treating Participants With Early Stage Classic Hodgkin LymphomaVenetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AMLTherapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and AdolescentsS0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaLeridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaLiposomal Daunorubicin in Treating Patients With Metastatic Breast CancerSWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic LeukemiaCombination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous LeukemiaCombination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous LeukemiaRadiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's LymphomaS9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaS0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AMLCombination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic LeukemiaDaunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid LeukemiaLiposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyCombination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCombination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCombination Chemotherapy in Treating Children With Non-Hodgkin's LymphomaDoxorubicin in Treating Patients With AIDS-Related Kaposi's SarcomaCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryA Prospective Randomized Comparison of HDAC vs AD in the Induction Chemothrapy for AML.Cytarabine, Idarubicin, Liposome-encapsulated Daunorubicin-Cytarabine or Decitabine in Treating Older Patients With Acute Myeloid LeukemiaBortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaTreatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS
P4844
Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway.Structure elucidation and antifungal activity of an anthracycline antibiotic, daunomycin, isolated from Actinomadura roseola.Binding of the anti-cancer drug daunomycin to DNA probed by second harmonic generation.Daunorubicin forms a specific complex with a secreted serine protease of Streptomyces peucetius.3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expressionDifferences in Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia
P921
description
antrasiklin ailesine mensup bir kemoterapik
@tr
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
name
Daunorrubicina
@es
Daunorrubicina
@gl
Daunorubicin
@de
Daunorubicin
@nl
Daunorubicin
@sh
Daunorubicin
@sr-el
Daunorubicină
@ro
Daunorubisiini
@fi
Daunorubisin
@tr
Davnorubicin
@sl
type
label
Daunorrubicina
@es
Daunorrubicina
@gl
Daunorubicin
@de
Daunorubicin
@nl
Daunorubicin
@sh
Daunorubicin
@sr-el
Daunorubicină
@ro
Daunorubisiini
@fi
Daunorubisin
@tr
Davnorubicin
@sl
altLabel
(+)-Daunomycin
@en
(8S-cis)-8-Acetyl-10-((3-amino ...... 1-methoxy-5,12-napthacenedione
@en
20830-81-3
@fr
23541-50-6
@fr
ATC kod L01DB02
@sr
Acetyladriamycin
@en
Anthracyline
@sr
C27H29NO10
@fr
C27H29NO10
@sr
Cerubidine
@sr
prefLabel
Daunorrubicina
@es
Daunorrubicina
@gl
Daunorubicin
@de
Daunorubicin
@nl
Daunorubicin
@sh
Daunorubicin
@sr-el
Daunorubicină
@ro
Daunorubisiini
@fi
Daunorubisin
@tr
Davnorubicin
@sl